Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Capital Expenditures (2014 - 2024)

Updated

Analysis

Grace Therapeutics (GRCE) Capital Expenditures (2014 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 1.36 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 301.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -3.30 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 237.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 573.00 Mn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 22,000.00
Mar 31, 2023 8,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 7,000.00
Sep 30, 2020 33,000.00
Jun 30, 2020 36,000.00
Mar 31, 2020 319,000.00
Dec 31, 2019 254,000.00
Sep 30, 2019 17,000.00
Jun 30, 2019 19,000.00
Mar 31, 2019 534,000.00
Dec 31, 2018 -139,402.04
Sep 30, 2018 -196,597.46
Jun 30, 2018 -222,470.64
Mar 31, 2018 618,721.62
Dec 31, 2017 -110,199.91
Sep 30, 2017 -71,766.57
Jun 30, 2017 -72,140.51
Nov 30, 2016 -540,585.70
Aug 31, 2016 -417,771.57
API Access

Grace Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GRCE&period=max&api_key=YOUR_API_KEY